Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Drug procurement developing countries

In line with reasons developed by Baker and Carapinha, Kinsley Wilson and colleagues also accept the premise that the state is primarily responsible for ensuring access to essential medicines. They suggest that countries should develop a National Drug Policy (NDP) and accompanying implementation plans. Countries need to establish adequate processes as far as the registration, selection, procurement, and distribution of drugs are concerned. [Pg.6]

Our focus is on a particular innovative procurement mechanism value-based pricing of medicines. While this is to date a mechanism largely experimented with in high-income countries, we think it is important because it shifts the attention of procurement policy from a market (often monopoly) price for an already developed drug to an assessment of how a drug will actually work in particular country contexts and for identified needs. Its attractiveness is in indicating ways forward in adapting procurement to a focus on population health benefit and patient needs. [Pg.253]


See other pages where Drug procurement developing countries is mentioned: [Pg.265]    [Pg.267]    [Pg.2857]    [Pg.707]    [Pg.908]    [Pg.253]    [Pg.74]    [Pg.89]    [Pg.94]    [Pg.100]   
See also in sourсe #XX -- [ Pg.79 ]




SEARCH



Countries

Developed countries

Developing countries

Developing countries development

Drug procurement

Procurement

© 2024 chempedia.info